First Eagle Investment Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-347,736
Closed -$49.6M 110
2020
Q2
$49.6M Buy
347,736
+84,577
+32% +$11.7M 0.16% 70
2020
Q1
$28.6M Sell
263,159
-1,884
-0.7% -$271K 0.1% 74
2019
Q4
$38.5M Buy
265,043
+28,867
+12% +$4.17M 0.11% 75
2019
Q3
$34.1M Buy
236,176
+129,786
+122% +$18.9M 0.1% 77
2019
Q2
$15.8M Buy
+106,390
New +$14.8M 0.04% 105
2017
Q1
Sell
-312,551
Closed -$34.5M 331
2016
Q4
$34.5M Buy
312,551
+48,563
+18% +$5.39M 0.09% 127
2016
Q3
$31.2M Buy
+263,988
New +$31.1M 0.08% 136

Other funds holding LH

First Eagle Investment Management's LH Position: Q3 2020 in Review

First Eagle Investment Management sold out of Labcorp (LH) in Q3 2020, closing a stake of 347,736 shares — an estimated $49.6M sold.

First Eagle Investment Management first reported a position in LH in Q3 2016 and held it in 7 quarters. The position peaked at $49.6M in Q2 2020. 809 funds tracked by Wall St. Rank hold LH as of Q3 2020.

  • First Eagle Investment Management reported no remaining Labcorp position as of Q3 2020 after selling out during the quarter.
  • First Eagle Investment Management sold 347,736 Labcorp shares in Q3 2020, an estimated $49.6M.
  • First Eagle Investment Management first reported a position in Labcorp in Q3 2016 and held it in 7 quarters.
  • First Eagle Investment Management's Labcorp position peaked at $49.6M in Q2 2020.
  • 809 funds tracked by Wall St. Rank held Labcorp as of Q3 2020.

Based on First Eagle Investment Management's 13F filing for Q3 2020, filed 10 Nov 2020.